KPV
C-terminal tripeptide of α-MSH, studied in inflammatory-signalling models.
7 papers · 2000–2026 · 6 journals
What the research explores
KPV appears in preclinical work concerned with inflammatory signalling, generally in cell culture and rodent models.
Areas of study:
- NF-κB pathway activity and nuclear translocation in cultured cells
- Pro-inflammatory cytokine expression in stimulated cell lines
- Experimental colitis models in rodents, examining mucosal inflammation endpoints
- Antimicrobial activity reported for the α-MSH C-terminal sequence against certain bacterial and fungal strains
- Uptake by intestinal epithelial peptide transporters, a transport question rather than an outcome question
Each of these describes what researchers have looked at. KPV is supplied strictly as a laboratory material and has no approved application in humans.
References
A reference list, not evidence. Inclusion means a paper discusses the compound — not that it supports any use, and not that it describes this product.
2026
2008
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, et al.
Gastroenterology
- Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease
Kannengiesser K, Maaser C, Heidemann J, et al.
Inflammatory bowel diseases
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation
2004
- alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells
Elliott RJ, Szabo M, Wagner MJ, et al.
The Journal of investigative dermatology
- alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells
2003
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides
Getting SJ, Schiöth HB, Perretti M
The Journal of pharmacology and experimental therapeutics
- Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides
2000
- The neuropeptide alpha-MSH in host defense
Catania A, Cutuli M, Garofalo L, et al.
Annals of the New York Academy of Sciences
- The neuroimmunomodulatory peptide alpha-MSH
Ichiyama T, Sato S, Okada K, et al.
Annals of the New York Academy of Sciences
- The neuropeptide alpha-MSH in host defense
For laboratory and research use only · Not for human or veterinary consumption · Not evaluated by the FDA
